Dr. Joseph Carozza, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 41 Miller Pl, Merrick, NY 11566 Phone: 516-546-7142 Fax: 201-918-2874 |
Dr. Jawahar Joseph D'souza, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1806 Old Mill Rd, Merrick, NY 11566 Phone: 516-867-7434 |
News Archive
To develop therapeutics that block this binding process, a team of researchers recently used an integrated computational approach to design nanobodies (Nbs) against the SARS-CoV-2 RBD, using neutralizing/monoclonal antibodies specific to RBD of the spike protein.
An experimental drug that acts in a novel way to lower cholesterol proved even more effective than statins and had few undesirable side effects, newly released data shows. The drug acts by modifying the way cholesterol levels are naturally controlled. A protein produced in the liver helps limit the amount of LDL, or "bad" cholesterol, that liver cells can remove from the bloodstream. The new drug, called REGN727, is a monoclonal antibody, made in a laboratory, that blocks the action of that protein.
The first patient has now been enrolled into the Phase 1 clinical trial sponsored by Viral Genetics' and supported by a donation from Scott and White Foundation. The trial will study Metabolic Disruption Technology (MDT) compounds in combination with an existing cancer therapy to treat drug-resistant ovarian cancer.
The prognosis for systemic lupus erythematosus (SLE), an autoimmune disease that mainly affects women in their reproductive years, has improved recently, prompting a shift toward improving quality of life.
› Verified 6 days ago